AHR and amyotrophic lateral sclerosis: A wide array of nutriceuticals have been proposed as beneficial in offsetting and slowing ALS-like progression in preclinical models, including green tea and its active polyphenol, epigallocatechin gallate (EGCG) [39], resveratrol, as an AhR antagonist and sirtuin-1 inducer [40], quercetin [41] and sodium butyrate [42], as a histone deacetylase inhibitor (HDACi) [43], as well as the synergistic utility of different combinations of such nutriceuticals [44].